(Q57212971)

English

Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen t

scholarly article by Soumitesh Chakravorty et al published January 2015 in Journal of Clinical Microbiology

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen t (English)

0 references

Mycobacterium tuberculosis

0 references

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Clifton E Barry

object named as

Clifton E Barry

10

0 references

8

object named as

Laura E Via

0 references

author name string

Soumitesh Chakravorty

1

0 references

Jong Seok Lee

2

0 references

Eun Jin Cho

3

0 references

Sandy S Roh

4

0 references

Laura E Smith

5

0 references

Jiim Lee

6

0 references

Cheon Tae Kim

7

0 references

Sang-Nae Cho

9

0 references

David Alland

11

0 references

language of work or name

0 references

publication date

January 2015

0 references

Journal of Clinical Microbiology

0 references

53

0 references

1

0 references

43-51

0 references

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Drug-susceptibility testing in tuberculosis: methods and reliability of results

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Molecular diagnostics in tuberculosis: basis and implications for therapy

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Multiplex allele specific PCR for rapid detection of extensively drug resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Rifampin drug resistance tests for tuberculosis: challenging the gold standard

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Fluorescent signatures for variable DNA sequences

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance

1 reference

https://api.crossref.org/works/10.1128%2FJCM.02059-14

21 January 2018

Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4290905

2 November 2018

Two liquid medium systems, mycobacteria growth indicator tube and MB redox tube, for Mycobacterium tuberculosis isolation from sputum specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4290905

2 November 2018

Rapid detection of rifampicin, isoniazid and streptomycin resistance in Mycobacterium tuberculosis clinical isolates by high-resolution melting curve analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25339395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/25339395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China

1 reference

https://pubmed.ncbi.nlm.nih.gov/25339395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.02059-14

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57212971&oldid=2139357714"